Daniel Aaron Gerber

Daniel Gerber practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Daniel Gerber's NPI, 1992125546, was assigned on April 22, 2014. Daniel Gerber graduated from George Washington University School of Medicine and Health Sciences in 2014. Daniel Gerber's California license number on file is A138539.

Daniel Gerber's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Daniel Gerber's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Daniel Gerber to 1 more hospital and 1 medical group, each named with a free account. Daniel Gerber's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Daniel Gerber practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Daniel Gerber's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Daniel Gerber is board certified in cardiovascular disease by the American Board of Internal Medicine. Daniel Gerber has a license on file in California.

CMS data shows 650 Medicare services from Daniel Gerber across 6 procedure codes in 2024, for 205 Medicare patients. Medicare paid $50,262 for them.

CMS counts 205 Medicare patients who saw Daniel Gerber in 2024. The largest group is 75 to 84, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Daniel Gerber's median patient age at 63, with 42% women.

In 2024, Daniel Gerber wrote 861 Medicare Part D claims for 123 patients. 79% of them were for generic drugs. CMS names the drug for 699 of them, across 21 drugs with 11 or more claims each, at $172,864 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Daniel Gerber for performance year 2024, reported as part of a group. Daniel Gerber accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Daniel Gerber, published from 2019 to 2025. 2024 was the busiest year, with 3. The most frequent topics are Critical Care, Shock, Cardiogenic and Cardiology. Daniel Gerber has published most often in J Card Fail. Daniel Gerber's most frequent co-authors are Erin Ann Bohula, MD, David A. Morrow, MD and Christopher F. Barnett, MD, MPH.

CMS Open Payments shows 12 general payments to Daniel Gerber from 7 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abiomed paid the most, $138.

Daniel Gerber graduated from George Washington University School of Medicine and Health Sciences in 2014.

Daniel Gerber is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.